NCT02376699 2023-05-01Safety Study of SEA-CD40 in Cancer PatientsSeagen Inc.Phase 1 Terminated159 enrolled
NCT03524898 2022-09-28NAPAGE: NAb-PAclitaxel and GEmcitabine in Advanced Soft Tissue SarcomaSwiss Cancer InstitutePhase 1/2 Terminated39 enrolled
NCT02317419 2016-07-26A Study of RO6927005 Either As Monotherapy (Part A) or in Combination With Gemcitabine and Nab-Paclitaxel (Part B) to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Clinical Activity in Patients With Mesothelin-positive Metastatic and/or Locally Advanced Malignant Solid TumorsHoffmann-La RochePhase 1 Terminated15 enrolled